Therapeutic Action
Antispasmodic
PDF page 167
Drug reference
Antispasmodic
PDF page 167
Spasms of the gastrointestinal tract and genitourinary tract
PDF page 167
Do not administer to patients with urethro-prostatic disorders, cardiac disorders, closed-angle glaucoma. May cause: urinary retention, dryness of the mouth, constipation, blurred vision, tachycardia. Administer with caution and under close supervision to patients taking other anticholinergic drugs (antidepressants, antipsychotics, H-1 antihistamines, antiparkinsonians, etc.). Administer with caution to patients with fever (may affect thermoregulation). Pregnancy: no contra-indication; NO PROLONGED TREATMENT Breast-feeding: no contra-indication; NO PROLONGED TREATMENT
PDF pages 167, 168
10 mg tablet
PDF page 167
Adult: 10 to 20 mg, to be repeated up to 3 or 4 times daily if necessary
PDF page 167
According to clinical response; no prolonged treatment.
PDF page 167
Oral antispasmodic drugs are not included in the WHO list of essential medicines.
PDF page 168
– – Below 25 °C
PDF page 168
10 to 20 mg, to be repeated up to 3 or 4 times daily if necessary
PDF page 167